Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
| Deadline | Title |
Funding Agency |
Discipline | Who's Eligible | Award Amount | Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 10/05/2023 | Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 7/31/2023 |
| Deadline: 9/14/2021 | Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 9/14/2021 | Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $900,000 | 4/18/2022 |
| Deadline: 5/25/2023 | NINDS Institutional Research Training Program (T32) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 2/07/2023 |
| Deadline: 10/23/2019 | Oscillatory Patterns of Gene Expression in Aging and Alzheimer’s Disease (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $3,000,000 | 4/18/2022 |
| Deadline: 6/16/2022 | Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 3/08/2022 |
| Deadline: 11/07/2022 | Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 8/15/2022 |
| Deadline: 10/05/2019 | Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01, R03, R21) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 7/28/2020 | Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $4,000,000 | 4/18/2022 |
| Deadline: 10/02/2019 | Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 11/09/2021 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 5/17/2024 | Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $7,500,000 | 6/21/2023 |
| Deadline: 6/16/2022 | Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,500,000 | 3/08/2022 |
| Deadline: 10/05/2023 | Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 8/09/2023 |
| Deadline: 3/30/2022 | U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trials Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 12/01/2022 | Contraceptive Development Research Center (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 8/02/2022 |
| Deadline: 10/05/2021 | Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 12/20/2022 | Translational Neural Devices (U44, UG3/UH3 Clinical Trial Required) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 1/04/2023 |
| Deadline: 3/18/2020 | Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 10/10/2023 | Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/27/2023 |
